Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Press Release
AANEM Virtual Industry Forum Oct 25, 2025 3:30 PM EDT Webcast Supporting Materials Virtual Industry Forum Presentation 4.2 MB
